Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 8, No 3 (2012) PHARMACOECONOMIC ASPECTS OF NICOTINE ADDICTION TREATMENT IN PATIENTS WITH ANGINA REQUIRING CARDIAC SURGERY Abstract  similar documents
A. V. Rudakova, M. S. Berezhnova
"... of varenicline is extremely high (in the analysis from the perspective of the health care system the cost ..."
 
Vol 14, No 1 (2018) SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking Abstract  similar documents
O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva
"... who continue to smoke. Smoking cessation is the most cost-effective strategy of cardiovascular disease ..."
 
Vol 15, No 1 (2019) Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation Abstract  similar documents
S. R. Gilyarevskiy
"... of varenicline and evidence of its clinical efficacy and safety, including in patients with concomitant ..."
 
Vol 9, No 4 (2013) VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... The problem of varenicline use in patients with cardiovascular diseases is discussed. Results ..."
 
Vol 11, No 5 (2015) Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism Abstract  similar documents
A. V. Rudakova
"... Aim. To assess the cost-effectiveness of apixaban in the treatment and secondary prevention ..."
 
Vol 8, No 1 (2012) ANALYSIS OF COST STRUCTURE FOR PHARMACOTHERAPY OF PATIENTS WITH STABLE ANGINA (THE CASE OF CARDIOLOGY DEPARTMENT OF TVER REGIONAL CLINICAL HOSPITAL) Abstract  similar documents
M. A. Demidova, N. N. Kirilenko
"... Aim. To analyze the cost structure for pharmacotherapy of patients with stable angina (SA ..."
 
Vol 7, No 3 (2011) COSTS OF THE HEALTH CARE IN RUSSIA ASSOCIATED WITH SMOKING Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina
"... Aim. To analyze costs of health care in Russia associated with smoking in 2009. Material ..."
 
Vol 7, No 2 (2011) SOCIO-ECONOMIC DAMAGE BY ACUTE CORONARY SYNDROME IN RUSSIAN FEDERATION Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, I. E. Koltunov, R. G. Oganov
"... . Material and Methods. Direct costs and economic losses associated with ACS were estimated. The structure ..."
 
Vol 5, No 5 (2009) THE COMPARATIVE COST-EFFICACY ANALYSIS OF VARIOUS ANTIHYPERTENSIVE THERAPIES Abstract  similar documents
S. V. Malchikova, E. I. Tarlovskaya
"... Aim. To perform the comparative cost-efficacy analysis of various antihypertensive therapies ..."
 
Vol 7, No 5 (2011) ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva
"... . The study was performed based on methodology for Cost of Illness evaluation. Expenses associated with INR ..."
 
Vol 9, No 4 (2013) COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE Abstract  similar documents
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
"... Aim. To compare direct medical costs of dabigatran and warfarin therapy in patients with non ..."
 
Vol 6, No 4 (2010) ECONOMIC EFFICIENCY OF THE IMPLEMENTATION OF THE PROGRAM OF CARDIOVASCULAR DISEASES MULTIFACTORIAL PREVENTION IN THE ORGANIZED COLLECTIVE OF TECHNICAL RESEARCH INSTITUTE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, S. V. Belonosova, J. M. Pozdnjakov, M. B. Khudyakov
"... consultation. Costs associated with cardiovascular diseases and risk factors (medical care consumption ..."
 
Vol 8, No 1 (2012) CHANGES IN THE COSTS OF HYPERTENSIVE CRISIS THERAPY DUE TO OPTIMIZATION OF DRUG SUPPLY IN THE PRE-ADMISSION CARE Abstract  similar documents
N. I. Gaponova, N. F. Plavunov, V. L. Baratashvili
"... Aim. To assess the changes in the costs of treatment of patients with hypertensive crisis (HC ..."
 
Vol 4, No 3 (2008) INFLUENCE OF HEALTH SCHOOL TRAINING OF PATIENTS WITH ISCHEMIC HEART DISEASE ON PHARMACOTHERAPY PROFILE AND COST (АВС/VEN ANALYSIS) Abstract  similar documents
A. V. Kontsevaja, А. М. Kalinina, E. J. Spivak
"... Aim. To study influence of patient training in Health School on pharmacotherapy profile and cost ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... in patients with NVAF in the Russian Federation. Aim. To evaluate the cost-effectiveness ratio of apixaban ..."
 
Vol 7, No 2 (2011) COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE Abstract  similar documents
V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko
"... Aim. To evaluate clinical and cost effectiveness of different reperfusion strategies in myocardial ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... of any medical technology is economic value and cost-effectiveness. The objective of this review ..."
 
Vol 11, No 3 (2015) PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT Abstract  similar documents
A. V. Rudakova
"... or oral anticoagulants that differ significantly in their efficacy, safety and cost of the therapy. Aim ..."
 
Vol 11, No 4 (2015) EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. V. Rudakova, N. V. Lomakin
"... . To assess the cost-effectiveness of VerifyNow P2Y12 platelet reactivity testing in patients after ACS ..."
 
Vol 14, No 2 (2018) PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
"... of treatment and clinical practice results was built. Cost-effectiveness analysis was done by comparing two ..."
 
Vol 7, No 4 (2011) VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, Zh. D. Kobalava, E. K. Shavarova
"... with arterial hypertension (HT) of 1-2 degrees, and to evaluate the cost effectiveness of original drug ..."
 
Vol 14, No 2 (2018) ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016 Abstract  PDF (Eng)  similar documents
A. N. Kontsevaya, O. M. Drapkina, Yu. A. Balanova, A. E. Imaeva, E. I. Suvorova, M. B. Khudyakov
"... (RF) in 2016, including the direct costs and the economic losses caused by reduced productivity ..."
 
Vol 14, No 3 (2018) ECONOMIC BURDEN OF HYPERCHOLESTEROLEMIA IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, M. B. Khudyakov, O. I. Karpov, O. M. Drapkina
"... includes not only cost of its correction, but also the cost of treatment of diseases and complications ..."
 
Vol 8, No 1 (2012) PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov
"... the cost-effectiveness of dabigatran etexilate versus warfarin prescribed in “real-world” settings from ..."
 
Vol 9, No 1 (2013) CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE Abstract  similar documents
M. I. Shupina, O. Ju. Korennova, E. N. Loginova
"... Aim. To study clinical and cost effectiveness of training of young patients with arterial ..."
 
Vol 10, No 4 (2014) RATIONAL PHARMACOTHERAPY BASED ON PHARMACOECONOMIC DATA AUDIT: PRINCIPLES AND APPLICATION IN BULGARIA Abstract  similar documents
T. Vekov
"... фармацевтических компаний при прохождении процедуры на включение в список разрешенных лекарств, затраты на которые ..."
 
Vol 10, No 2 (2014) PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM Abstract  PDF (Eng)  similar documents
A. M. Kalinina, A. V. Kontsevaya
"... . Cost-effectiveness of primary prevention, including the one of MI, has been conclusively showed ..."
 
Vol 5, No 3 (2009) CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, Yu. M. Pozdnyakov, S. V. Belonosova, M. B. Khudyakov
"... (with estimation of the total costs, costs for one studied person and costs for revealing of one person needed ..."
 
Vol 9, No 1 (2013) PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review Abstract  similar documents
T. S. Romanenko, A. V. Kontsevaya, S. V. Fitilev
"... therapy, conducted during the last decades inRussia. Despite the increased interest to the issue of cost ..."
 
Vol 11, No 6 (2015) Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events Abstract  similar documents
O. V. Shatalova
"... of the health care system. The cost analysis, "cost-effectiveness" analysis, "impact on the budget” analysis ..."
 
Vol 13, No 1 (2017) CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova
"... Aim. To compare cost-effectiveness of the use of direct factor Xa inhibitors rivaroxaban ..."
 
Vol 3, No 4 (2007) THE ALGORITHMIC MODEL OF LABORATORY DIAGNOSTICS OPTIMIZATION Abstract  similar documents
G. I. Nazarenko, O. V. Andropova
"... of algorithmic approach is able to optimize diagnostics and its costs. Various algorithmic models, their features ..."
 
Vol 4, No 5 (2008) CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
M. V. Soura
"... ’s comparative cost analysis on metoprolol tartrate (Betaloc) and metoprolol succinate (Betaloc ZOK) usage ..."
 
Vol 8, No 2 (2012) PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION Abstract  similar documents
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchikova, M. V. Avksentieva
"... (LVMI) were considered. Cost-effectiveness method of analysis was used. Results. In V/A group 75 ..."
 
Vol 7, No 1 (2011) THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY Abstract  similar documents
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich
"... Aim. Тo compare the cost-effectiveness of antihypertensive therapy based on a generic and original ..."
 
Vol 14, No 5 (2018) Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation Abstract  similar documents
Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov
"... in 2016, including direct costs of the health care system  and indirect economic losses due to premature ..."
 
Vol 12, No 1 (2016) Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease Abstract  similar documents
E. I. Tarlovskaya, T. I. Chudinovskikh
"... Aim. To compare the efficacy and cost/effectiveness ratio of the original and generic bisoprolol ..."
 
Vol 6, No 4 (2010) PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov
"... Aim. To perform cost-effectiveness analysis of 24 weeks antihypertensive therapy based ..."
 
Vol 10, No 4 (2014) PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE Abstract  similar documents
E. I. Tarlovskaya, Y. A. Balandina, N. S. Maximchuk-Kolobova
"... without ischemic heart disease (n=56) were included into the study. Blood pressure (BP) dynamics and cost ..."
 
Vol 1, No 1 (2005) ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES Abstract  similar documents
V. V. Yakusevich
"... it possible to decrease the costs of treatment. From the other side with the advent of big number of copies ..."
 
Vol 13, No 2 (2017) THESES OF PSYCHOSOMATIC MEDICINE Abstract  similar documents
F. I. Belyalov
"... , increase healthcare costs. Antidepressants decrease severity of anxiety and depression, as well as diminish ..."
 
Vol 11, No 3 (2015) ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... of them the cost of anticoagulation therapy was determined on the basis of the average weighted prices ..."
 
Vol 7, No 5 (2011) COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... , creatine phosphokinase were evaluated every 4 weeks. Cost-effectiveness ratio was calculated. Results. 11 ..."
 
Vol 9, No 3 (2013) NICOTINE REPLACEMENT THERAPY OF THE TOBACCO ADDICTION IN PREVENTION OF CARDIORESPIRATORY DISEASES Abstract  similar documents
M. G. Gambaryan
"... of cardiorespiratory diseases. Smoking cessation is the most cost-effective measure for prevention of cardiovascular ..."
 
Vol 6, No 6 (2010) EFFICACY AND SAFETY OF SINUS RHYTHM RESTORATION WITH AMIODARONE AND PROPAFENONE IN OUTPATIENTS, ECONOMIC ASPECTS (BASED ON DATA OF N.A. SEMASHKO NORTHERN MEDICAL CLINICAL CENTER) Abstract  similar documents
T. A. Istomina, E. V. Serdechnaya, L. A. Kulminskaya, B. A. Tatarskiy, E. V. Kazakevich, V. L. Lipskiy, S. I. Martyushov
"... ), and amiodarone 600-800 mg daily. The cost/effectiveness ratio (CER) was estimated. This ratio shows the cost ..."
 
Vol 7, No 5 (2011) ECONOMIC BENEFITS OF LEFT VENTRICULAR HYPERTROPHY REGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchicova, M. V. Avksentieva, I. E. Sapozhnikova, Y. A. Balandina
"... 516 772.42 RUR for every 1 000 patients. It would reduce the total costs per patient during 10 years ..."
 
Vol 3, No 5 (2007) CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, J. B. Zverkov, V. V. Pisarev, I. E. Koltunov, V. G. Belolipetskaya, S. J. Martsevich
"... Amlorus and Norvasc, respectively. Cost of Amlorus therapy per patient was 221 rbl/month in comparison ..."
 
Vol 8, No 2 (2012) COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
O. P. Bobrova, M. M. Petrova
"... of cost minimization analysis. Results. Original enalapril dose necessary to achieve the target blood ..."
 
Vol 14, No 4 (2018) Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing Abstract  similar documents
A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik
"... » group direct cost for inpatient AC therapy was significantly higher than in «adherent» group 4041 rubles ..."
 
Vol 5, No 4 (2009) CLINICO-ECONOMICAL ANALYSIS OF THE TREATMENT EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES Abstract  similar documents
L. A. Haisheva, S. V. Shlyk, T. Y. Bykovskaya
"... was performed according to “cost-efficacy” approach at the end of 3 month therapy. Results. About 50 ..."
 
Vol 6, No 4 (2010) DIAGNOSTICS AND TREATMENT OF MITRAL VALVE PROLAPSE Abstract  similar documents
D. A. Kuzhel, G. V. Matyushin, E. A. Savchenko
"... кардиохирургической коррекции заболевания. Методом выбора в этих случаях является проведение пластики митрального ..."
 
Vol 12, No 4 (2016) The implementation of health care aimed at the cessation of tobacco use, treatment of tobacco dependence and consequences of tobacco consumption in the Russian Federation Abstract  similar documents
S. A. Boytsov, P. K. Yablonskiy, M. G. Gambaryan, O. A. Sukhovskaya, O. M. Drapkina
"... международными рекомендациями по лечению табачной зависимости [6, 7], включающими фармакотерапию (варениклин и ..."
 
Vol 15, No 2 (2019) Cardiovascular medicine prices as an indicator of access to medicines and their rational use Abstract  similar documents
C M. Razzakova, L. E. Ziganshina
"... procurement prices of these medicines in hospitals. Also we performed pharmacoeconomic cost-minimisation ..."
 
Vol 10, No 2 (2014) EVALUATION OF ATRIAL CONTRACTILE FUNCTION DISORDERS AND FIBROSIS AS PREDICTORS OF CHRONIC HEART FAILURE Abstract  similar documents
O. M. Drapkina, E. V. Cherkunova
"... Chronic heart failure (CHF) is a major health problem in many countries now, and the cost ..."
 
Vol 2, No 3 (2006) APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY Abstract  similar documents
S. V. Nedogoda
"... применение у кардиохирургических пациентов. ..."
 
Vol 7, No 6 (2011) COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... ) and microalbuminuria (MAU) and to calculate cost-effectiveness ratio (CER). Material and methods. Patients (n=75 ..."
 
Vol 4, No 4 (2008) COMPARISON OF DIFFERENT STRATEGIES OF ANTIHYPERTENSIVE THERAPY IN OUT-PATIENT CLINIC Abstract  similar documents
O. A. Plejko, A. O. Konradi
"... минимизации стоимости (cost mini- minization analysis); 2) анализ эффективности затрат или стоимостный анализ ..."
 
Vol 4, No 3 (2008) ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES Abstract  similar documents
E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich
"... carvedilol has lower cost of treatment than this in original carvedilol. ..."
 
Vol 7, No 4 (2011) METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE Abstract  similar documents
M. S. Berezhnova
"... фармакологические методики работы с пациентами, данные об эффективности затрат на оказание помощи в отказе от ..."
 
Vol 4, No 4 (2008) ECONOMIC REASONS FOR GENERIC CHOICE Abstract  similar documents
N. P. Kutishenko, S. Y. Martsevich, S. N. Tolpygina, J. V. Lukina
"... - жением затрат на здравоохранение в целом. Однако од- новременное появление большого количества копий од ..."
 
Vol 11, No 4 (2015) MULTI-CHANNEL VOLUME SPHYGMOGRAPHY IN CARDIOANGIOLOGICAL SCREENING OF THE ADULT POPULATION Abstract  similar documents
R. A. Khokhlov, N. I. Ostroushko, A. E. Gaydashev, D. V. Kirsanov, N. M. Akhmedzhanov
"... be regarded as the basis for low-cost and efficient system of cardioangiological screening. ..."
 
Vol 9, No 3 (2013) ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING Abstract  similar documents
N. S. Maksimchuk-Kolobova, E. I. Tarlovskaya, S. V. Malchikova
"... 1000 patients. It would reduce the total costs per patient during 10 years. V/A therapy is able to save ..."
 
Vol 8, No 2 (2012) THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya
"... to treatment, induces additional costs or may be a reason of new side effects. Additional (to standard therapy ..."
 
Vol 5, No 4 (2009) TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS Abstract  similar documents
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky
"... , treatment costs and safety). The place of ACE inhibitors and ARB in modern therapy of cardiovascular ..."
 
Vol 14, No 2 (2018) NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov
"... is easy to follow and well accepted by patients despite of twice-daily dosing regimen. Healthcare cost ..."
 
Vol 13, No 1 (2017) MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
N. F. Puchinian, N. V. Furman, L. I. Malinova, P. V. Dolotovskaya
"...   затрат сил и времени для самообразования. Цель обзора – в краткой форме помочь практикующим врачам ..."
 
Vol 14, No 2 (2018) RATIONAL PHARMACOTHERAPY IN CARDIOLOGY: FROM MINIMIZATION OF EXPENSES TO EFFECTIVE MANAGEMENT Abstract  similar documents
N. A. Nikolayev, Yu. P. Skirdenko, S. S. Bunova, A. V. Ershov
"... than the class or cost of medicines, the original or generic nature of the drugs, or their dosage ..."
 
Vol 4, No 1 (2008) PHARMACOEPIDEMIOLOGICAL STUDY OF DOCTORS HABITS IN PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN TOWN OF OREL Abstract  similar documents
G. I. Shvets, S. V. Povetkin
"... % of doctors prescribed pharmacotherapy, which cost 100 to 500 rubles per months. Not rational combinations ..."
 
Vol 14, No 2 (2018) WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY Abstract  similar documents
R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin
"... . The main reason limiting the widespread use of NOACs is the high cost of these drugs. Conclusion ..."
 
Vol 14, No 6 (2018) Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation Abstract  PDF (Eng)  similar documents
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee
"... analyzing the cost of drugs in licensed pharmacies, it was found that drugs containing furosemide ..."
 
Vol 3, No 5 (2007) ON THE ANNIVERSARY OF ACADEMICIAN R.G. OGANOVA Abstract  similar documents
N. Dolgushina
"... основная задача государства сегодня), затраты на здравоохранение снизятся. Профилактика приведет к снижению ..."
 
Vol 11, No 5 (2015) Three-year dynamics and unsolved problems of lipid-lowering therapy Abstract  similar documents
V. A. Sergeeva
"... taken to correct and control lipid metabolism disorders were insignificant within 3 years. High costs ..."
 
Vol 6, No 2 (2010) EVALUATION BY PRACTICING DOCTORS OF THE MODERN PHARMACOTHERAPY POSSIBILITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE. RESULTS OF DOCTOR INTERVIEW IN MOSCOW AND VORONEZH Abstract  similar documents
S. Yu. Martsevich, L. Yu. Drozdova, Yu. V. Lukina, N. V. Sinyagina, T. G. Kheliya
"... , respectively, considered high cost of statins as the main limit for its implementation. Conclusion. On one ..."
 
Vol 15, No 3 (2019) Medication Adherence: does Patient Participation in Randomized Clinical Trials Affect on it? Abstract  similar documents
N. O. Vasyukova, Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich, O. I. Zvonareva
"... of the patient can significantly worsen the effectiveness of treatment and leads to increased health care costs ..."
 
Vol 10, No 5 (2014) OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... rate and related costs at improvement of outpatient treatment quality. We should note that evaluation ..."
 
Vol 10, No 6 (2014) VALIDATION OF THE MACNEW QUESTIONNAIRE FOR THE ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ISHEMIC HEART DISEASE Abstract  PDF (Eng)  similar documents
N. V. Pogosova, A. A. Kursakov, I. H. Boycharov, S. Höfer, N. Oldridge
"... therapy and working capacity examina- tion in the analysis of cost-effectiveness of me- dical care ..."
 
Vol 11, No 1 (2015) TRANSCATHETER AORTIC VALVE IMPLANTATION. STATE OF THE PROBLEM AND PROSPECTS IN RUSSIA Abstract  similar documents
T. E. Imaev, A. E. Komlev, R. S. Akchurin
"... перенесенных кардиохирургических вме- шательств, лучевой терапии грудной клетки, выра- женный кальциноз ..."
 
Vol 5, No 1 (2009) PROBLEM OF GENERIC REPLACEMENT: ADVANTAGES AND DISADVANTAGES Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich
"... Разработка нового лекарственного средства яв- ляется весьма трудоемким и дорогостоящим процес- сом. Затраты ..."
 
Vol 5, No 6 (2009) TO THE JUBILEE OF ACADEMICIAN LEO ANTONOVICH BOKERIA: CURING THE HEARTS Abstract  similar documents
"... истории болезни кардиохирургического профиля, в базе данных которой более 20 тысяч боль- ных, и один из ..."
 
Vol 12, No 3 (2016) LOW ADHERENCE TO TREATMENT AFTER MYOCARDIAL INFARCTION: CAUSES AND WAYS OF ADJUSTMENT CONSIDERING PSYCHO-EMOTIONAL STATE OF PATIENTS Abstract  PDF (Eng)  similar documents
E. A. Kuzheleva, K. N. Borel', A. A. Garganeeva
"... 's prescriptions (14%); a large number of prescribed drugs (12%); high cost of drugs (4%). The structure ..."
 
Vol 8, No 4 (2012): РЕКОМЕНДАЦИИ ЕВРОПЕЙСКОГО ОБЩЕСТВА КАРДИОЛОГОВ ПО ДИАГНОСТИКЕ И ЛЕЧЕНИЮ ЗАБОЛЕВАНИЙ ПЕРИФЕРИЧЕСКИХ АРТЕРИЙ Abstract  similar documents
, , , , , , , , , , , , , , , , , , , ,
"... устройства является не- дорогим методом и требует минимальных затрат вре- мени. Роль ЛПИ в диагностике ..."
 
Vol 9, No 5 (2013) ASSESSING FACTORS THAT FORM PATIENT’S ATTITUDE TO TREATMENT PRECEDING HOSPITALIZATION FOR ACUTE CORONARY SYNDROM (DATA OF QUESTIONNAIRE WITHIN THE LIS REGISTER) Abstract  PDF (Eng)  similar documents
Yu. V. Lukina, M. L. Gynzburg, V. P. Smirnov, S. Yu. Martsevich, N. P. Kutishenko, A. V. Fokina, E. V. Daniels
"... the importance of lowering drug costs. 11 patients of 272 respondents demanded more care from their doctor; 4 ..."
 
Vol 11, No 4 (2015) DRUGS EFFICIENCY AND SAFETY: THE ROLE OF PHARMACEUTICAL INDUSTRY Abstract  similar documents
F. I. Belyalov
"... - работка нового препарата требует все более значи- тельных ресурсов. По данным Tufts CSDD 2014 Cost Study ..."
 
Vol 9, No 6 (2013) DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. D. Deev, S. A. Boytsov
"... by 16.6% from 2010 to 2030 and di- rect costs for its treatment – by 196%. Authors ex- plain expected ..."
 
Vol 7, No 1 (2011) ATHEROSCLEROSIS: HOW TO START UP A "COUNT DOWN" CLOCK? WE DON'T KNOW, WE CAN NOT OR WE DO NOT WANT? Abstract  similar documents
L. N. Malay
"... протезирование АоК, что значительно уменьшило стоимость затрат на лечение и снизило риск периопе- рационных ..."
 
Vol 13, No 4 (2017) HEALTHCARE RESOURCES UTILIZATION AND TEMPORARY DISABILITY IN POPULATION AGED 50-64 ACCORDING TO THE EPIDEMIOLOGICAL ESSE-RF STUDY Abstract  PDF (Eng)  similar documents
A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, A. D. Deev, A. V. Kapustina, G. A. Muromtseva, S. E. Evstifeeva, S. A. Shalnova
"... medical as- sistance is connected to financial cost for people out of job (for instance, in the USA ..."
 
Vol 3, No 2 (2007) AMERICAN COLLEGE OF CARDIOLOGY, AMERICAN HEART ASSOCIATION AND EUROPEAN SOCIETY OF CARDIOLOGY (2006) GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, J.Y. Le Heuzey, G.N. Kay, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, S. Wann
"... тромбоэмболии, связанные сФП, являют- ся причинами высокой заболеваемости, смертности и затрат на лечение. В ..."
 
Vol 7, No 5 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES Abstract  similar documents
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
"... затрат на постоянный лабораторный контроль, стоимость самого препарата значительно превысила рас- ходы на ..."
 
Vol 6, No 1 (2010) COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova
"... дженерические (ко- пированные). Использование дженериков позволяет значительно снизить затраты на лечение. В ..."
 
Vol 9, No 4 (2013) EFFECT OF SIMVASTATIN ON THE PROGNOSIS AND THE CHANGES OF THE CLINICAL STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE. THE RESULTS OF THE 12 MONTH RANDOMIZED, OPEN COMPARATIVE STUDY Abstract  similar documents
V. V. Yakusevich, A. Yu. Malygin, A. V. Kabanov
"... угрозой для жизни и требует огромных ор- ганизационных усилий и финансовых затрат на лече- ние и ..."
 
Vol 9, No 4 (2013) THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev
"... AL, et al. Cost-Effectiveness of Cytochrome P450 2C19 Genotype Screening for Selection of ..."
 
Vol 4, No 1 (2008) RUN-DOWN AND COMMENTS ON COMPLETED MULTICENTRAL CONTROLLED STUDIES Abstract  similar documents
S. R. Gilyarevskiy
"... затрат време- ни на каждый сеанс. Из-за болезненных ощущений при вы- полнении акупунктуры полностью ..."
 
Vol 12, No 1 (2016) The Moriscos-Green scale: the pros and cons of universal test, correction of mistakes Abstract  PDF (Eng)  similar documents
Yu. V. Lukina, S. Yu. Martsevich, N. P. Kutishenko
"... больных и увеличению затрат на лечение. Вопросы оценки и прогнозирования приверженности к лечению у ..."
 
Vol 4, No 3 (2008) EUROPEAN HEART HEALTH CHARTER Abstract  similar documents
статья Редакционная
"... потребление алкоголя и психосо- циальный стресс. Затраты Затраты на ССЗ а экономике Европы оцениваются в 169 ..."
 
Vol 10, No 1 (2014) TO KEEP CONTINUITY OF GENERATIONS Abstract  similar documents
R. S. Karpov, N. V. Dolgushina
"... кардиохирургических центров регио- на Сибири и Дальнего Востока. - Ваши дети пошли по стопам родителей или вы- брали ..."
 
Vol 8, No 6 (2012) SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE Abstract  similar documents
E. V. Filippov, S. S. Yakushin
"... дохода ежегодно от ИБС по- гибает 1,42 млн человек [31], а затраты на лечение это- го заболевания только ..."
 
Vol 3, No 2 (2007) VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY Abstract  similar documents
D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes
"... штата США, было отмечено снижение затрат на одного пациента в среднем на 2100 долл. США в год при ..."
 
Vol 5, No 2 (2009) DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov
"... , инвалидности и преждевременной смер- ти, что оборачивается значительными экономически- ми затратами и ..."
 
Vol 6, No 2 (2010) VALSARTAN IN EVERYDAY CLINICAL PRACTICE IN RUSSIA: ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik
"... затрат на здравоохранение и даже падению производительности труда [7-9]. Проблема низкой при- верженности ..."
 
Vol 10, No 6 (2014) ALCOHOLIC CARDIOMYOPATHY: BASIC ASPECTS OF EPIDEMIOLOGY, PATHOGENESIS AND PHARMACOTHERAPY Abstract  similar documents
A. O. Yusupova
"... эффективности и безопасности варениклина при лечении алкогольной зависимости. Необходимо подчеркнуть, что этот ..."
 
1 - 100 of 256 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)